Publicaciones en las que colabora con ANA ISABEL TORRES SUÁREZ (25)

2023

  1. Cannabidiol (CBD) use in breast cancer chemotherapy

    Medicinal Usage of Cannabis and Cannabinoids (Elsevier), pp. 373-383

  2. Capacitación de alumnos de pregrado en la generación de contenidos divulgativos de Farmacia y Tecnología Farmacéutica para su difusión en entornos virtuales

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  3. XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

    Sociedad Española de Farmacia Industrial y Galénica

2022

  1. Active targeted nanoformulations via folate receptors: State of the art and future perspectives

    Pharmaceutics, Vol. 14, Núm. 1

  2. Aplicación de las TIC en asignaturas teórico-prácticas del grado en Farmacia: tecnología farmacéutica y biofarmacia y farmacocinética

    Jornada «Aprendizaje Eficaz con TIC en la UCM» (Universidad Complutense de Madrid), pp. 43-53

  3. Current status of nanomedicine for breast cancer treatment

    Targeted Nanomedicine for Breast Cancer Therapy (Elsevier), pp. 65-110

  4. Limitations and challenges in the stability of cysteamine eye drop compounded formulations

    Pharmaceuticals, Vol. 15, Núm. 1

2021

  1. Matrix tablets based on a novel poly (magnesium acrylate) hydrogel for the treatment of inflammatory bowel diseases

    International Journal of Pharmaceutics, Vol. 608

2020

  1. CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer

    International Journal of Pharmaceutics, Vol. 574

  2. Controlled release of highly hydrophilic drugs from novel poly(Magnesium acrylate) matrix tablets

    Pharmaceutics, Vol. 12, Núm. 2

  3. Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 154, pp. 246-258

  4. PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: In vitro and in Ovo assessment

    Pharmaceutics, Vol. 12, Núm. 5

  5. Stability characteristics of cannabidiol for the design of pharmacological, biochemical and pharmaceutical studies

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 1150

2019

  1. Adquisición de competencias transversales mediante debates asíncronos: Diseño e implementación en las enseñanzas de tecnología farmacéutica

    Innovación Docente e Investigación en Ciencias de la Salud (Dykinson), pp. 309-320

  2. Capecitabine safety profile, innovative and generic adjuvant formulation of nonmetastatic colorectal cancer

    Farmacia Hospitalaria, Vol. 73, Núm. 5, pp. 158-162

  3. Current status of nanomedicine in the chemotherapy of breast cancer

    Cancer Chemotherapy and Pharmacology, Vol. 84, Núm. 4, pp. 689-706

  4. Quality of life in non-metastasic colorectal cancer patients in Folfox or Xelox therapy

    Farmacia Hospitalaria, Vol. 43, Núm. 2, pp. 56-60

2018

  1. New trends in the therapeutic approach to metastatic colorectal cancer

    International Journal of Medical Sciences, Vol. 15, Núm. 7, pp. 659-665

2017

  1. Cáncer colorrectal: prevención y tratamiento

    Anales de la Real Academia Nacional de Farmacia, Vol. 83, Núm. 2, pp. 188-199

2016

  1. Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas

    Expert Opinion on Investigational Drugs, Vol. 25, Núm. 11, pp. 1311-1323